Workflow
Here's Why You Should Consider Buying Atara Biotherapeutics Stock
ATRAAtara Biotherapeutics(ATRA) ZACKS·2025-01-08 16:46

Atara Biotherapeutics (ATRA) is a nimble allogeneic T cell immunotherapy company with several near-term catalysts. This Zacks Rank #2 (Buy) company boasts a pipeline of differentiated therapies across a range of oncology and autoimmune indications from its proven EBV T cell platform.FDA Decision on ATRA's Tab-cel Expected Next WeekThe company’s biologics license application (BLA) seeking approval for its lead product candidate, tabelecleucel (tab-cel), in the United States is under priority review with the ...